NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Persistence Market Research (P) Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

 

NewswireTODAY - /newswire/ - New York, NY, United States, 2017/06/28 - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In terms of volume share, market is expected to increase at 7.8% CAGR during 2016-2024. The report by PMR titled ‘Australia Nitric Acid Market: Industry Analysis and Forecast, 2016-2024’, provides an in-depth analysis on the performance of Australian nitric acid market, along with important trends and factors influencing the market.

Growing mining activities and expansion in capacity of facilities of ammonium nitrate are the factors expected to fuel the growth of nitric acid market in Australia during 2016-2024. An increase in demand for ammonium nitrate explosives has resulted in an increase in production of ammonium nitrate. This is expected to fuel demand for nitric acid during 2016-2024.

Due to the high dependency of ammonium nitrate explosives on mining exploration activities, the increase in mining exploration activities in Australia, especially in Queensland and Western Australia is set to witness growth in the production as well as consumption in the country. However, the rise in alternatives being developed for ammonium nitric-based explosives could hamper the growth of Australian nitric acid market.
In terms of application of nitric acid, the explosives accounted for volume share of 90% in 2015. However, registering 8.0% CAGR during the forecast period, explosives is expected to influence the Australian nitric acid market. Non-fuming product is expected to have largest share in nitric acid market in the country, registering 8.2% CAGR during 2016-2024. This will also create an opportunity of $580.4 million in the region.

The market value of non-fuming product is expected to rise to $1.24 billion by 2024-end from $609.7 million in 2015. Fuming nitric acid applied in litho printing and precious metal refining is anticipated to act as a driving force in growth of fuming segment, by application. In 2015, in terms of value, commercial grade accounted for 95.3% market share of nitric acid in Australia. Commercial grade is expected to expand at 7.9% CAGR between 2016 and 2024. In 2015, by application of nitric acid, explosives accounted for 95.4% Australia nitric acid market share on basis of value. The explosives market share in terms of value is expected to register 8.0% CAGR during 2016-2024.

Region-wise, the report has segmented Australia nitric acid market into Queensland, New South Wales, Western Australia, Victoria and rest of Australia. Among all these regions, Western Australia and Queensland are considered to be the largest market in Australia for nitric acid. In 2015, both the regions together accounted for 58.0% market share. According to the report, during 2016-2024, Queensland, Western Australia and New South Wales will be considered as the most attractive markets in Australia for nitric acid. Nitric acid consumption in all these three regions together was projected to reach 1,444.9 kilotons in 2016 end.

The report has also profiled some of the leading players in nitric acid market in Australia such as Energy & Fertilizers, Orica Limited, Incitec Pivot Limited and Wesfarmers Chemicals.

About Persistence Market Research (PMR)

Persistence Market Research (persistencemarketresearch.com) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Persistence Market Research (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Rahul Singh - PersistenceMarketResearch.com 
646-568-7751 sales[.]persistencemarketresearch.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Persistence Market Research (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Persistence Market Research (P) Ltd / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS
Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients
U.S. FDA Grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia
Additional Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer in South Korea
BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions
Ipsen Expands Early Development Pipeline with Simcere Zaiming’s Innovative Antibody Drug Conjugate
Ipsen Update on Phase II FALKON Trial in Patients with Ultra-rare Bone Disease, Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen Completes Acquisition of ImCheck Therapeutics, Expanding Oncology Pipeline
NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025
Ono Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera
JFCR, NEC, and Taiho to Develop Cancer Vaccines Utilizing Whole-Genome Information
Ono Receives Supplemental Approval of Combination Therapy with BRAFTOVI® Capsule, a BRAF Inhibitor, for the Indication of Colorectal Cancer
WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition in the CRDMO Industry

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)